Kezar Life Sciences, Inc. - stock earnings

KZR Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
Aug. 8, 2024 BeforeMarket - / - - - / 600000 3.0 million

KZR Quarterly earnings

DateEarningsRevenue
2024Q1 -21.7 million USD ? USD
2023Q4 -32.3 million USD -5.4 million USD
2023Q3 -23.1 million USD 7.0 million USD
2023Q2 -24.3 million USD ? USD
2023Q1 -20.2 million USD ? USD
2022Q4 -16.3 million USD ? USD
2022Q3 -16.8 million USD ? USD
2022Q2 -16.1 million USD ? USD
2022Q1 -16.2 million USD ? USD
2021Q4 -14.2 million USD ? USD
2021Q3 -14.5 million USD ? USD
2021Q2 -13.0 million USD ? USD
2021Q1 -13.0 million USD ? USD
2020Q4 -10.9 million USD ? USD
2020Q3 -11.3 million USD ? USD
2020Q2 -9.5 million USD ? USD
2020Q1 -10.0 million USD ? USD
2019Q4 -9.6 million USD ? USD
2019Q3 -9.1 million USD ? USD
2019Q2 -8.7 million USD ? USD
2019Q1 -7.6 million USD ? USD
2018Q4 -5.8 million USD ? USD
2018Q3 -5.7 million USD ? USD
2018Q2 -6.8 million USD ? USD
2018Q1 -4.9 million USD ? USD
2017Q4 -2.3 million USD ? USD
2017Q3 -2.1 million USD ? USD
2017Q2 -1.9 million USD ? USD
2017Q1 -2.3 million USD ? USD
2016Q4 -9.0 million USD ? USD

KZR Yearly earnings

DateEarningsRevenue
2023 -101.9 million USD 7.0 million USD
2022 -65.3 million USD ? USD
2021 -53.3 million USD ? USD
2020 -39.0 million USD ? USD
2019 -31.5 million USD ? USD
2018 -23.2 million USD ? USD
2017 -8.5 million USD ? USD
2016 -9.0 million USD ? USD

KZR

Price: $0.77

52 week price:
0.67
3.13

Earnings Per Share: -1.40 USD

P/E Ratio: -0.79

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 409400

Market Capitalization: 56.2 million

Links: